BCR and chronic myelogenous leukemia, BCR-ABL1 positive: BCR::ABL1T315I is a common point mutation that exhibits resistance to all earlier-generation TKIs, remaining one major obstacle to vanquishing CML (Braun et al., 2020; Hughes and Shanmuganathan, 2022).